Re-applied treatment with plasma exchange followed by bortezomib resulted in moderate but sustained clinical improvement.<h4>Discussion</h4>Anti septin-5 encephalitis represents a rare but treatable and therefore relevant differential diagnosis in patients with cerebellar ataxia. The gene discussed is SEPTIN5; the disease is aceruloplasminemia.